In recent trading session, Calidi Biotherapeutics Inc (AMEX:CLDI) saw 1.59 million shares changing hands at last check today with its beta currently measuring 1.17. Company’s recent per share price level of $0.87 trading at -$0.48 or -35.51% at last check today assigns it a market valuation of $16.41M. That most recent trading price of CLDI’s stock is at a discount of -1831.03% from its 52-week high price of $16.80 and is indicating a premium of 16.09% from its 52-week low price of $0.73. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.25 million shares which gives us an average trading volume of 1.77 million if we extend that period to 3-months.
Calidi Biotherapeutics Inc (AMEX:CLDI) trade information
Upright in the red during last session for losing -35.51%, in the last five days CLDI remained trading in the red while hitting it’s week-highest on Tuesday, 01/07/25 when the stock touched $0.87 price level, adding 41.61% to its value on the day. Calidi Biotherapeutics Inc’s shares saw a change of -24.29% in year-to-date performance and have moved -26.22% in past 5-day. Calidi Biotherapeutics Inc (AMEX:CLDI) showed a performance of -54.89% in past 30-days. Number of shares sold short was 0.59 million shares which calculate 0.88 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5.5 to the stock, which implies a rise of 84.18% to its recent value today. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 9. It follows that stock’s current price would drop -129.89% in reaching the projected high whereas dropping to the targeted low would mean a loss of -129.89% for stock’s current value.
Calidi Biotherapeutics Inc (CLDI) estimates and forecasts
Statistics highlight that Calidi Biotherapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -42.57% of value to its shares in past 6 months, showing an annual growth rate of 74.10% while that of industry is 16.50. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Calidi Biotherapeutics Inc (AMEX:CLDI)’s Major holders
Insiders are in possession of 18.16% of company’s total shares while institution are holding 2.71 percent of that, with stock having share float percentage of 3.31%. Investors also watch the number of corporate investors in a company very closely, which is 2.71% institutions for Calidi Biotherapeutics Inc that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Bridgeway Funds Inc-Ultra Small Company Market Fund are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024, the former fund manager was holding 30.96 shares of worth $27221.0 or 0.15% of the total outstanding shares. The later fund manager was in possession of 10.0 shares on Sep 30, 2024, making its stake of worth around $8791.0 in the company or a holder of 0.05% of company’s stock.
